» Authors » Jiming Si

Jiming Si

Explore the profile of Jiming Si including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 32
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang F, Tang J, Lou J, Wang Q, Ma K, Qiao R, et al.
Transl Cancer Res . 2022 Oct; 11(9):3337-3342. PMID: 36237231
Background: Approximately 10-25% of patients with small cell lung cancer (SCLC) have brain metastases at the time of diagnosis. Radiotherapy is a common treatment for brain metastases, but the relapse...
2.
Ma K, Huang F, Wang Y, Kang Y, Wang Q, Tang J, et al.
Cancer Med . 2022 May; 11(22):4389-4397. PMID: 35521981
Tumor mutational burden (TMB) is an emerging predictive marker of response to immune checkpoint inhibitor therapies. We evaluated the correlation between clinical indicators and high-throughput sequencing results and TMB in...
3.
Si J, Jin J, Sai J, Liu X, Luo X, Fu Z, et al.
Hum Cell . 2022 Mar; 35(3):924-935. PMID: 35301686
Circular RNAs (circRNAs) are emerging as crucial regulators in tumorigenesis and aggressive progression. However, their biological roles in non-small cell lung cancer (NSCLC) remain largely unknown. Here, by performing circRNA...
4.
Jin J, Wang H, Si J, Ni R, Liu Y, Wang J
Clin Sci (Lond) . 2019 Jan; 133(2):381-392. PMID: 30626729
Long non-coding RNAs (lncRNAs) have been reported to play a vital role in non-small-cell lung cancer (NSCLC). ZEB1-AS1 overexpression predicts a poor prognosis in osteosarcoma and colorectal cancers. In the...
5.
Jin J, Si J, Liu Y, Wang H, Ni R, Wang J
Respir Res . 2018 Oct; 19(1):197. PMID: 30290817
Background: Potential relationship between serum soluble programmed cell death ligand 1 and prognosis of small cell lung cancer is not well explored. The aim of the study was to reveal...